Status:
SUSPENDED
Protein, Amino Acids & Insulin & Glucagon Secretion in Humans
Lead Sponsor:
Minneapolis Veterans Affairs Medical Center
Conditions:
Type 2 Diabetes
Metabolic Syndrome
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the effect of various foods and/or food substances such as fats or proteins on the blood glucose and insulin concentrations in people with and without type 2 ...
Detailed Description
Various foods or food substances are given as a test meal. The metabolic response is determined at various times after the administration of the meal (e.g. blood glucose, and other hormones and metabo...
Eligibility Criteria
Inclusion
- Subjects with or without type 2 diabetes
- C-Peptide \> 1.5 ng/ml
- Able to come to the Minneapolis VA Medical Center on several occasions over 2-4 weeks
Exclusion
- Body mass index \> 40
- hematologic abnormalities
- liver disease
- kidney disease
- congestive heart failure
- life threatening malignancies
Key Trial Info
Start Date :
August 1 1982
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 6 2017
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01471509
Start Date
August 1 1982
End Date
November 6 2017
Last Update
November 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minneapolis VA Health Care System
Minneapolis, Minnesota, United States, 55417